Recent advances in radiotherapy for head and neck cancers

Ear, Nose and Throat Journal

Volumn 80, Issue 10, 2001, Pages

  Chou, R H ^a   Wilder, R B ^a   Wong, M S ^a   Forster, K M ^a  

^a Craven Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEAM THERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; INTRAOPERATIVE PERIOD; PARTICLE RADIATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

EID: 0034784728     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130108001008     Document Type: Article

References (67)

1. Hereditary and environmental risk factors: Clinical and laboratory risk markers for head and neck, especially oral, cancer and precancer
2. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck
3. Molecular changes in oral cancer may reflect aetiology and ethnic origin
4. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma
5. Clinical dose-response curves of human malignant epithelial tumours
6. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
7. The role of altered fractionation in head and neck cancers
8. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
9. Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience
10. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: A comparison of two fractionation schedules
11. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
12. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience
13. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx
14. 3-D Conformal radiotherapy in head and neck cancer. The Washington University experience
15. Three-dimensional treatment planning and conformal radiation therapy: Preliminary evaluation
16. The single-isocentre treatment of head and neck cancer: Time gain using MLC and automatic set-up
17. Fractionated stereotactically guided radiotherapy of head and neck tumors: A report on clinical use of a new system in 195 cases
18. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: One-year results
19. The initial results in the fractionated 3-dimensional stereotactic irradiation of clivus chordomas
20. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer
21. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control
22. Postoperative radiotherapy of paraspinal sinus tumours: A challenge for intensity modulated radiotherapy
23. Intensity-modulated radiotherapy: First results with this new technology on neoplasms of the head and neck
24. Clinical and financial issues for intensity-modulated radiation therapy delivery
25. Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy
26. Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses
27. Long-term outcomes after meningioma radiosurgery: Physician and patient perspectives
28. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: Impact on local control
29. The radiobiology of radiosurgery: Rationale for different treatment regimes for AVMs and malignancies
30. Fractionated stereotactic radiotherapy: Rationale and methods
31. Acoustic neuroma: Potential benefits of fractionated stereotactic radiosurgery
32. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas
33. Reirradiation of brain and skull base tumors with fractionated stereotactic radiotherapy
34. Improved trigeminal and facial nerve tolerance following fractionated stereotactic radiotherapy for large acoustic neuromas
35. Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial
36. Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors
37. Neutron therapy in malignant salivary gland tumors: Results at European centers
38. Proton therapy for tumors of the skull base
39. Experience in charged particle irradiation of tumors of the skull base: 1977-1992
40. Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: The Lawrence Berkeley Laboratory experience
41. Considerations in fractionated proton radiation therapy: Clinical potential and results
42. Base of skull and cervical spine chordomas in children treated by high-dose irradiation
43. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma
44. Review of current protocols for protontherapy in USA
45. Chordoma of the cranial base: The McGill experience
46. Radiation therapy of tumours involving the skull base
47. Chordoma: Long-term follow-up after radical photon irradiation
48. Intraoperative radiotherapy of head and neck cancer
49. Intraoperative radiation therapy for recurrent head and neck cancer
50. Intraoperative radiation therapy (IORT) for head and neck cancer
51. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program
52. Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials
53. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
54. Induction chemotherapy as part of a new treatment strategy to preserve the larynx in advanced laryngeal cancer
55. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
56. Combined-modality therapy for head and neck cancer
57. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials
58. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
59. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
60. Chemotherapy as a part of each treatment fraction in a twice-a-day hyperfractionated schedule: A new chemoradiotherapy approach for advanced head and neck cancer
61. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer
62. Amifostine-a radioprotector in locally advanced head and neck tumors
63. Oral glutamine to alleviate radiation-induced oral mucositis: A pilot randomized trial
64. Chemoprevention with interferon alfa and 13-cis retinoic acid in the adjunctive treatment of head and neck cancer
65. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma